Cargando…

Continuous subcutaneous insulin infusion is associated with a reduced rate of microvascular complications

Detalles Bibliográficos
Autores principales:	Zabeen, Bedowra, Craig, Maria E, Pryke, Alison, Chan, Albert K F, Cho, Yoon Hi, Aguirre, Paul Benitez, Hing, Stephen, Donaghue, Kim C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429052/ http://dx.doi.org/10.1186/1687-9856-2015-S1-O33

Ejemplares similares

Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve Abnormality
por: Zabeen, Bedowra, et al.
Publicado: (2016)

Risk Factors Associated with Microalbuminuria in Children and Adolescents with Diabetes in Bangladesh
por: Zabeen, Bedowra, et al.
Publicado: (2018)

Continuous subcutaneous insulin infusion: practical issues
por: Saboo, Banshi D., et al.
Publicado: (2012)

Vitamin D Deficiency Is Associated With Retinopathy in Children and Adolescents With Type 1 Diabetes
por: Kaur, Harleen, et al.
Publicado: (2011)

Higher frequency of cardiovascular autonomic neuropathy in youth with type 2 compared to type 1 diabetes: Role of cardiometabolic risk factors
por: Varley, Benjamin J., et al.
Publicado: (2022)

Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?
por: Rosinha, Patrícia, et al.
Publicado: (2022)

A Continuous Subcutaneous Insulin Infusion Needle Break
por: George, Minu M., et al.
Publicado: (2015)

Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes
por: Rotella, Francesco, et al.
Publicado: (2013)

Young people with type 1 diabetes on insulin pump therapy could fast safely during COVID–19 pandemic Ramadan: A telemonitoring experience in Bangladesh
por: Zabeen, Bedowra, et al.
Publicado: (2020)

Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion
por: Ziegler, Ralph, et al.
Publicado: (2021)

Continued Reduction in the Prevalence of Retinopathy in Adolescents With Type 1 Diabetes: Role of insulin therapy and glycemic control
por: Downie, Elizabeth, et al.
Publicado: (2011)

Outcomes for continuous subcutaneous insulin infusion users in young adults from lower socioeconomic backgrounds
por: McKee, Alexis M., et al.
Publicado: (2021)

Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics
por: Pozzilli, Paolo, et al.
Publicado: (2015)

Continuous subcutaneous insulin infusion and flash glucose monitoring in diabetic hemiballism-hemichorea
por: Qiang, Wei, et al.
Publicado: (2020)

Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
por: Hagell, Peter, et al.
Publicado: (2020)

Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
por: Li, Feng-fei, et al.
Publicado: (2018)

Continuous Subcutaneous Insulin Infusion Characteristics in Type 1 Diabetes Children and Adolescents in Qatar
por: Petrovski, Goran, et al.
Publicado: (2018)

Insulin Pump for Type 2 Diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes
por: Reznik, Yves, et al.
Publicado: (2013)

Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine
por: Hauzenberger, Jasmin R., et al.
Publicado: (2017)

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
por: King, Allen B., et al.
Publicado: (2016)

Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin
por: Reid, Laura J., et al.
Publicado: (2021)

Sensory neuropathy in young people with type 1 diabetes: a systematic review
por: Jayasuriya, Michelle, et al.
Publicado: (2015)

Diurnal variation of carbohydrate insulin ratio in adult type 1 diabetic patients treated with continuous subcutaneous insulin infusion
por: Nakamura, Tomoaki, et al.
Publicado: (2014)

Polymorphic Basal Rates of Continuous Subcutaneous Insulin Infusion among Taiwanese Children with Type 1 Diabetes
por: Lin, Chia-Hung, et al.
Publicado: (2015)

Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
por: Lyu, Fu-ping, et al.
Publicado: (2020)

Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion
por: Aleppo, Grazia, et al.
Publicado: (2021)

Continuous Subcutaneous Insulin Infusion Therapy Resulting in Improved Glycemic Control in Patient With Low Health Literacy
por: Mandal, Shobha, et al.
Publicado: (2021)

Prevention of retinopathy in type 1 diabetes: a systematic review and meta-analysis
por: Virk, Sohaib, et al.
Publicado: (2015)

Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear
por: Rini, Christopher James, et al.
Publicado: (2015)

Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy
por: Li, Feng-fei, et al.
Publicado: (2018)

Dental caries and bacterial load in saliva and dental biofilm of type 1 diabetics on continuous subcutaneous insulin infusion
por: COELHO, Ana, et al.
Publicado: (2018)

Continuous Subcutaneous Insulin Infusion in Children: A Pilot Study Validating a Protocol to Avoid Hypoglycemia at Initiation
por: Manousaki, Despoina, et al.
Publicado: (2017)

The Lived Experience of Continuous Subcutaneous Insulin Infusion in Adults With Type 1 Diabetes Mellitus: A Phenomenological Inquiry
por: Callahan Fagan, V. Renee, et al.
Publicado: (2021)

Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes
por: Scott, Emma S., et al.
Publicado: (2021)

Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
por: Bode, Bruce W., et al.
Publicado: (2017)

Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands
por: Roze, Stephané, et al.
Publicado: (2019)

Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes
por: GAO, GUAN-QI, et al.
Publicado: (2014)

Effectiveness of Multiple Daily Injections or Continuous Subcutaneous Insulin Infusion for Children with Type 1 Diabetes Mellitus in Clinical Practice
por: Gong, Chun-xiu, et al.
Publicado: (2014)

Study protocol for a randomised controlled trial of insulin delivery by continuous subcutaneous infusion compared to multiple daily injections
por: Blair, Jo, et al.
Publicado: (2015)

Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study
por: Calles-Escandón, Jorge, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_abmlmns33nuoftlro93rop3tic